What are BioLife Solutions's total assets?

BioLife Solutions (BLFS) holds $400.9M in total assets, up 1.5% year over year.

How much debt does BioLife Solutions have?

BioLife Solutions carries $17.4M in total debt against $372.2M of shareholders' equity, a debt-to-equity ratio of 0.05.

How much cash does BioLife Solutions have?

BioLife Solutions holds $22.8M in cash and equivalents.

Can BioLife Solutions cover its short-term obligations?

Its current ratio is 7.30 — current assets exceed current liabilities.

Where does BioLife Solutions's balance sheet data come from?

Every line is extracted from BioLife Solutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

BioLife Solutions BLFS Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$22.82M-65.9%	$33.04M-65.4%	$29.48M+22.0%	$31.9M+44.7%	$66.95M+125%
Short-term investments	$58.17M+169%	$55.89M+508%	$49.47M+385%	$49.86M+311%	$21.64M+38.9%
Accounts receivable, net	$13.06M+42.4%	$7.95M-6.2%	$10.84M-39.5%	$10.06M-44.3%	$9.17M-50.6%
Inventories	$32.83M+19.1%	$30.16M+3.9%	$27.83M-13.5%	$27.69M-14.8%	$27.57M-36.5%
Raw materials	$12.11M+23.0%	$10.56M-10.3%	$9.12M-28.4%	$8.62M-39.8%	$9.85M-59.5%
Work in process	$5.8M+29.3%	$6.37M+56.1%	$4.04M-39.3%	$4.8M-6.0%	$4.49M-33.4%
Finished goods	$14.92M+12.8%	$13.22M+0.5%	$14.68M+14.6%	$14.27M+9.2%	$13.23M+7.2%
Total current assets	$133.22M+1.6%	$136.56M-8.2%	$126.57M+41.6%	$125.43M+42.2%	$131.13M+17.4%
Property and equipment, net	$14.5M+120%	$14.71M+146%	$11.1M-37.3%	$7.67M-55.6%	$6.61M-68.6%
Accumulated depreciation	$5.36M+19.1%	$4.93M+14.7%	$4.95M-51.6%	$4.72M-50.9%	$4.5M-57.9%
Operating lease right-of-use assets	6.4%0.0%	6.4%-1,055,299,994%	6.4%+0.6%	6.4%+2.0%	6.4%+2.1%
Goodwill	$208.59M-1.8%	$208.59M0.0%	$212.3M-5.5%	$212.3M-5.5%	$212.3M-5.5%
Intangible assets, net	$3.93M-55.6%	$4.26M-23.5%	$7.45M-59.5%	$8.15M-57.8%	$8.86M-56.2%
Deferred tax assets	$751K+37.3%	$683K+12.0%	$618K+3.0%	$529K-32.7%	$547K-36.1%
Other non-current assets	$3.05M+707%	$3.05M+718%	$2.42M+793%	$378K+56.8%	$378K+54.3%
Total assets	$400.91M+1.5%	$405.88M+1.6%	$392.08M+2.7%	$387.24M+3.3%	$395.14M-1.6%
Accounts payable	$3.75M+13.7%	$1.49M-55.8%	$2.89M-24.7%	$3.21M-23.8%	$3.3M-33.8%
Accrued expenses	$3.26M-24.9%	$5.85M-17.8%	$5.91M+106%	$4.96M+77.1%	$4.34M+2.1%
Accrued compensation	$4.03M+7.2%	$5.93M+13.4%	$4.84M+1.3%	$4.19M-4.4%	$3.76M+3.0%
Deferred revenue	$206K+76.1%	$195K+89.3%	$154K-64.6%	$162K-74.7%	$117K-60.9%
Current portion of long-term debt	$2.5M-76.1%	$5M-54.3%	$7.49M-38.7%	$10.05M-5.3%	$10.45M+21.2%
Operating lease liabilities, current	$2.32M+26.2%	$2.24M+53.7%	$2.18M-21.9%	$2.17M-13.5%	$1.84M-30.6%
Income taxes payable	$2.11M-46.2%	$2.28M-46.2%	$3.68M-15.4%	$3.58M-26.4%	$3.93M-27.2%
Total current liabilities	$18.25M-34.2%	$22.98M-29.8%	$27.15M-15.6%	$28.31M-8.1%	$27.72M-28.3%
Long-term debt	$2.5M0.0%	$0-100%	$0-100%	$0-100%	$2.5M-84.1%
Operating lease liabilities, non-current	$10.04M-17.5%	$10.66M-15.7%	$11.01M-27.5%	$11.6M+4.7%	$12.17M-3.3%
Operating Lease Liabilities (Total)	$12.36M-11.7%	$12.9M-9.4%	$13.19M-26.7%	$13.76M+1.4%	$14M-8.0%
Other non-current liabilities	——	——	——	——	——
Total liabilities	$28.68M-32.6%	$34M-32.8%	$38.34M-31.8%	$40.09M-25.1%	$42.52M-37.7%
Preferred stock	$0—	$0—	$0—	$0—	$0—
Common stock	150M0.0%	150M+319,049%	150M0.0%	150M0.0%	150M0.0%
Additional paid-in capital	$710.81M—	$711.4M—	$704.33M—	——	——
Retained earnings	-$338.51M-0.9%	-$339.7M-1.4%	-$350.77M-0.9%	-$351.39M-1.6%	-$335.55M-3.2%
Accumulated other comprehensive income (loss)	-$120K-464%	$132K+450%	$130K+163%	$71K+113%	$33K+106%
Total stockholders' equity	$372.23M+5.6%	$371.89M+6.6%	$353.74M+8.7%	$347.16M+8.0%	$352.62M+5.8%
Total liabilities and stockholders' equity	$400.91M+1.5%	$405.88M+1.6%	$392.08M+2.7%	$387.24M+3.3%	$395.14M-1.6%
Available-for-Sale Debt Securities - Amortized Cost	$88.79M+118%	$87.01M+530%	$68.79M+357%	$68.26M+361%	$40.66M+148%
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	$57.93M—	$7.52M—	$6.18M—	——	——
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)	$57.93M—	$7.52M—	$6.18M—	——	——
Available-for-Sale Debt Securities - Unrealized Loss Position	$151K—	$5K—	$2K—	——	——
AFS and Trading Securities - Unrealized Loss Position Fair Value	$57.93M—	$7.52M—	$6.18M—	——	——
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	$57.93M—	$7.52M—	$6.18M—	——	——
Allowance for Doubtful Accounts	$27K-76.9%	$22K-85.6%	$105K-89.0%	$134K-87.4%	$117K-93.3%
Allowance for Doubtful Accounts Receivable (Current)	$27K-76.9%	$22K-85.6%	$105K-89.0%	$134K-87.4%	$117K-93.3%
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)	——	——	——	——	——
Cash, Cash Equivalents, and Marketable Securities	$57.93M+480%	$7.52M+141%	$6.18M-59.1%	$15.57M+5.1%	$10M-39.1%
Available For Sale Securities Debt Securities Current	$58.17M+169%	$55.89M+508%	$49.47M+385%	$49.86M+311%	$21.64M+38.9%
Cash Cash Equivalents And Short Term Investments	$111.5M+3.6%	$120.2M+10.1%	$98.4M+150%	$100.2M+172%	$107.6M+133%
Finished goods	$14.92M+12.8%	$13.22M+0.5%	$14.68M+14.6%	$14.27M+9.2%	$13.23M+7.2%
Deferred Tax Assets and Other Non-Current Assets	——	——	——	——	——
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——	——
Intangible Assets Gross (Excluding Goodwill)	$10.62M-58.2%	$10.62M-58.2%	$25.39M-31.7%	$25.39M-31.7%	$25.39M-31.7%
Investments - Amortized Cost Basis	$88.79M+118%	$87.01M+530%	$68.79M+357%	$68.26M+361%	$40.66M+148%
Net Investment in Lease	$7.11M-29.8%	$7.47M-29.3%	$7.63M-47.0%	$9.53M-8.3%	$10.13M-6.0%
Net Operating Loss Carryforwards	——	——	——	——	——
Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Noncurrent	$30.5M+60.1%	$31.25M+575%	$19.44M+298%	$18.47M+587%	$19.06M+2,218%
Intangible assets — net	——	——	——	——	——
Other intangible assets—net	$3.93M-55.6%	$4.26M-23.5%	$7.45M-59.5%	$8.15M-57.8%	$8.86M-56.2%
Operating lease right-of-use assets	$7.11M-29.8%	$7.47M-29.3%	$7.63M-47.0%	$9.53M-8.3%	$10.13M-6.0%
Other non-current assets	——	——	——	——	——
Property, plant and equipment at cost	$19.86M+78.9%	$19.65M+89.2%	$16.05M-42.6%	$12.39M-53.9%	$11.1M-65.0%
Operating Lease Right-of-Use Assets in Other Assets	$7.11M-29.8%	$7.47M-29.3%	$7.63M-47.0%	$9.53M-8.3%	$10.13M-6.0%
Software and Technology Licenses, Net	——	——	——	——	——
Other Commercial Liabilities	$3.26M-24.9%	$5.85M-17.8%	$5.91M+106%	$4.96M+77.1%	$4.34M+2.1%
Accrued expenses and other current liabilities	$7.58M-7.8%	$11.97M-1.2%	$10.91M+29.1%	$9.31M+14.6%	$8.21M-7.3%
Accrued Income Taxes, Current	——	——	——	——	——
Accrued Liabilities, Current	$3.26M-24.9%	$5.85M-17.8%	$5.91M+106%	$4.96M+77.1%	$4.34M+2.1%
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——	——
Operating Lease Liability Payments Due	——	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——	——
Debt Maturity - 2024	——	——	——	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$1K-96.0%	$3K-91.4%	$8K-83.7%	$15K-76.9%	$25K-69.1%
Operating Lease Liability Payments - 2026 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——	——
Total debt	$17.36M-35.6%	$17.9M-40.7%	$20.68M-47.3%	$23.82M-33.8%	$26.95M-34.2%
Total Carrying Value of Debt	$2.5M-80.7%	$5M-68.7%	$7.5M-62.7%	$10.07M-52.4%	$12.97M-46.8%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	48.8M+2.7%	48.2M+2.8%	48M+3.8%	47.8M+3.8%	47.5M+4.1%
Common Stock Shares Outstanding	——	——	——	——	——
Convertible Preferred Stock Authorized Shares	1M0.0%	1M0.0%	1M0.0%	1M0.0%	1M0.0%
Additional paid-in capital	$710.81M+3.3%	$711.4M+4.0%	$704.33M+4.6%	$698.42M+4.6%	$688.09M+4.4%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$49K+2.1%	$48K+2.1%	$48K+4.3%	$48K+4.3%	$48K+4.3%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—
Investments - Gross Unrealized Losses	$57.93M—	$7.52M—	$6.18M—	——	——
Number of Exercisable Options	——	——	——	——	——
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment Award Options Outstanding - Number	17K-86.6%	117K-7.9%	117K-26.2%	117K—	127K—
Unrealized Gains on Investments	$31K-26.2%	$137K+389%	$133K+151%	$78K+7,700%	$42K+4,100%
Unrealized Losses on Investments (Before Tax)	$151K+1,578%	$5K+25.0%	$1K—	$7K-50.0%	$9K-30.8%
Weighted Average Exercise Price of Outstanding Options	$4.08+86.3%	$2.22+1.4%	$2.22+2.8%	$2.22—	$2.19—
Cumulative Cost Basis	$88.79M+118%	$87.01M+530%	$68.79M+357%	$68.26M+361%	$40.66M+148%
Number of Class Action Lawsuits	——	——	——	——	——
Allowance for doubtful accounts	$27K-76.9%	$22K-85.6%	$105K-89.0%	$134K-87.4%	$117K-93.3%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$151K+1,578%	$5K+25.0%	$1K—	$7K-50.0%	$9K-30.8%
Gross Unrealized Gains	$31K-26.2%	$137K+389%	$133K+151%	$78K+7,700%	$42K+4,100%
Total	$88.79M+118%	$87.01M+530%	$68.79M+357%	$68.26M+361%	$40.66M+148%
Available for sale investments	$88.67M+118%	$87.14M+530%	$68.92M+357%	$68.34M+361%	$40.69M+148%
Cash and cash equivalents, end of period	——	——	——	——	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$150M0.0%	$150M0.0%	$150M0.0%	$150M0.0%	$150M0.0%
Common stock, shares issued (in shares)	$48.83M+2.7%	$48.2M+2.8%	$47.97M+3.8%	$47.85M+3.8%	$47.55M+4.1%
Common Stock, Shares, Outstanding	$48.83M+2.7%	$48.2M+2.8%	$47.97M+3.8%	$47.85M+3.8%	$47.55M+4.1%
Long-term debt, gross	$2.5M-80.7%	$5M-68.7%	$7.5M-62.7%	$10.07M-52.4%	$12.97M-46.8%
Debt Securities, Available-for-sale, Amortized Cost, Noncurrent	$30.6M+60.7%	$31.21M+575%	$19.4M—	$18.43M—	$19.04M—
Amortized cost of available-for-sale debt securities, current	$58.2M+169%	$55.8M+508%	$49.39M+385%	$49.83M+311%	$21.62M+38.7%
Less than 12 months	$57.93M—	$7.52M—	$6.18M—	——	——
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	——	——	——	——	——
Debt Securities, Available-for-Sale, Unrealized Loss, Current	$51K+2,450%	$0-100%	$0—	$4K—	$2K—
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss	$151K—	$5K—	$2K—	——	——
Debt Securities, Available-for-Sale, Unrealized Loss, Noncurrent	$100K—	$5K—	$1K—	——	——
Debt Securities, Available-for-Sale, Unrealized Loss Position	$57.93M—	$7.52M—	$6.18M—	——	——
Gross unrealized Gains, current portion	$28K+55.6%	$94K+395%	$84K+265%	$35K+3,400%	$18K+1,700%
Gross unrealized Gains, long term	$3K—	$43K—	$49K—	——	——
Deferred income taxes	$198K+52.3%	$189K+52.4%	$189K+89.0%	$175K-9.3%	$130K-32.6%
Discontinued operations, outstanding minimum lease payments for the lease terminations	——	——	——	——	——
Finite-lived Intangible Asset, Expected Amortization, After Year Four	——	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	$6.68M-59.6%	$6.36M-59.8%	$17.94M-4.4%	$17.24M-3.5%	$16.54M-2.5%
2028	——	——	——	——	——
2030	——	——	——	——	——
Remainder of 2026	——	——	——	——	——
2027	——	——	——	——	——
2029	——	——	——	——	——
Indefinite- lived intangible impairment	$10.62M-58.2%	$10.62M-58.2%	$25.39M-31.7%	$25.39M-31.7%	$25.39M-31.7%
Lessee Operating Lease Liability Payments Due	——	——	——	——	——
Thereafter	——	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——	——
Remainder of 2026	——	——	——	——	——
Number of class action complaints	——	——	——	——	——
Operating Lease Weighted Average Discount Rate Percent	$0.060.0%	$0.060.0%	$0.06+10.3%	$0.06+45.5%	$0.06+48.8%
Operating Loss Carryforwards	——	——	——	——	——
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$1M0.0%	$1M0.0%	$1M0.0%	$1M0.0%	$1M0.0%
Purchase Obligation	——	——	——	——	——
Sales and income tax payable	$2.1M-46.2%	$2.3M-46.5%	$3.7M-2.6%	$3.6M-18.2%	$3.9M-22.0%
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$17K-86.6%	$117K-7.9%	$117K-26.2%	$117K—	$127K—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$4.08+86.3%	$2.22+1.4%	$2.22+2.8%	$2.22—	$2.19—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	——	——	——	——	——
Purchase Obligation	——	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about BioLife Solutions.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are BioLife Solutions's total assets?: BioLife Solutions (BLFS) holds $400.9M in total assets, up 1.5% year over year.
How much debt does BioLife Solutions have?: BioLife Solutions carries $17.4M in total debt against $372.2M of shareholders' equity, a debt-to-equity ratio of 0.05.
How much cash does BioLife Solutions have?: BioLife Solutions holds $22.8M in cash and equivalents.
Can BioLife Solutions cover its short-term obligations?: Its current ratio is 7.30 — current assets exceed current liabilities.
Where does BioLife Solutions's balance sheet data come from?: Every line is extracted from BioLife Solutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.